Centum Electronics (517544) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
25 Oct, 2026Executive summary
Q1 FY25 consolidated revenue was INR 2,459 Mn, down 0.6% YoY; adjusted for Ind AS 115 net accounting, revenue was INR 2,645 Mn, up 7%.
Consolidated EBITDA was INR 156 Mn and net loss was INR 38.43 Mn; the order book stood at INR 16,740 Mn as of June 30, 2024.
FY25 gross-basis growth guidance remains 18%–20%, with H2 expected to bring stronger BTS billing and margin recovery.
Financial highlights
Consolidated EBITDA declined 26.1% YoY to INR 156 Mn; net loss was INR 38.43 Mn versus net profit of INR 14.49 Mn in Q1 FY24.
Standalone revenue was INR 1,333 Mn, up 4.1% YoY; EBITDA was INR 128 Mn and PAT was INR 45 Mn, down 26.9% and 36.6%, respectively.
Total income was INR 2,471.32 Mn; total expenses were INR 2,501.58 Mn and EPS was a loss of INR 2.45.
Consolidated EBITDA margin was 6.34%; standalone EBITDA margin was 9.60%.
Outlook and guidance
FY25 consolidated revenue growth target remains 18%–20% on a gross basis; net accounting is expected to reduce reported top-line growth by ~5%–6%.
FY25 EBITDA margin targets are 13%+ standalone and 10%–12% consolidated; a 10%–11% consolidated target was also reiterated, excluding other income.
Management expects ~70% of BTS defense invoicing in H2, with most margin recovery in Q3 and Q4; some domestic BTS deliveries shifted to H2.
Medium-term consolidated EBITDA margin objective is 13%–15%, supported by subsidiary improvement and higher BTS contribution.
Latest events from Centum Electronics
- Q2 revenue rose 52% YoY as the order book reached Rs 19.5 billion.517544
Q2 26/27 - FY25 targets rely on a stronger H2 led by BTS delivery and subsidiary performance.517544
Q2 24/25 - Ausar provision and Canadian losses weighed on consolidated results despite standalone growth.517544
Q3 24/25 - Q4 margins rebounded as the order book supported FY26 growth targets despite subsidiary losses.517544
Q4 24/25 - Revenue and margins improved YoY, while subsidiary losses and ER&D delays persist.517544
Q1 25/26 - Standalone growth strengthened, while subsidiary losses constrained consolidated margins.517544
Q2 25/26 - Standalone growth and defense prospects offset overseas restructuring losses and impairments.517544
Q3 25/26 - Revenue and order growth were offset by overseas restructuring losses.517544
Q4 25/26 - Order book rose 31% as Q1 margins softened and reported profit included discontinued operations.517544
Q1 26/27